Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia
NCT07471516
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Congenital Dyserythropoietic Anemia (CDA)
Interventions
DRUG:
zoledronic acid
Sponsor
Institute of Hematology & Blood Diseases Hospital, China